For breast cancer patients, Penn researchers are comparing costly proton therapy with standard radiation
The Perelman School of Medicine’s Justin E. Bekelman is leading a $12 million study to compare the effects of proton therapy and standard radiation treatment on breast cancer.
・ From Philadelphia Inquirer